Description
Listing of 3,11,111 equity shares of Vivo Bio tech Ltd issued on preferential basis to promoters with lock-in period until February 2027.
Summary
BSE has listed 3,11,111 new equity shares of Vivo Bio tech Ltd (Scrip Code: 511509) effective August 6, 2025. These shares were issued to promoters on a preferential basis following warrant conversion at Rs. 45 per share with a lock-in period until February 28, 2027.
Key Points
- 3,11,111 equity shares of Rs. 10 each issued at premium of Rs. 35
- Allotted to promoters on preferential basis pursuant to warrant conversion
- Issue price: Rs. 45 per share
- Shares rank pari-passu with existing equity shares
- Distribution numbers: 17164817 to 17475927
- ISIN: INE380K01017
Regulatory Changes
No regulatory changes. Standard listing procedure for converted warrants.
Compliance Requirements
- Trading members informed of new securities availability for trading
- Promoter shares subject to lock-in restrictions as per SEBI regulations
Important Dates
- Allotment Date: April 8, 2025
- Trading Commencement: August 6, 2025
- Lock-in Period Expires: February 28, 2027
Impact Assessment
Minimal immediate market impact as shares are locked-in until February 2027. The conversion represents fulfillment of warrant obligations and strengthens promoter commitment to the company.
Impact Justification
Routine listing of converted warrants with minimal market impact due to promoter lock-in